|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
29.09.25 - 22:09
|
Anaptys Announces Intent to Separate Biopharma Operations from Substantial Royalty Assets by Year-end 2026 (GlobeNewswire EN)
|
|
|
SAN DIEGO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, announced today that its Board of Directors approved plans to explore separating its business into two independent, publicly traded companies, each poised for strong, sustainable growth. Referred to as “Royalty Management Co” and as “Biopharma Co” in this press release, the two companies' different business models enable investors to align their investment philosophies and portfolio allocation with the strategic opportunities and financial objectives of each company.“Anaptys is strategically positioned with multiple attractive, high-potential assets, including our development-stage pipeline consisting of rosnilimab, ANB033 and ANB101, as well as substantial potential royalties and milestones payments from our ongoing financial collaborations with GSK and Vanda,” said Daniel Faga, president and chief executive officer ...
|
|
|
|
|
|
|
|
|
27.08.25 - 08:48
|
Hari: Tariffs Won′t Stop India from Buying Russian Oil (Bloomberg)
|
|
|
Additional US tariffs on Indian goods have come into effect on August 27, doubling the existing 25% duty imposed on August 7 to 50%. Meanwhile oil held a large drop as investors weighed the fallout from higher tariffs over India's imports of Russian crude. Vandana Hari, Founder of VANDA Insights told Bloomberg's Horizons Middle East and Africa anchor Joumanna Bercetche there's no signs the tariffs will have a major shift in local refiners' purchasing patterns. (Source: Bloomberg)...
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
